Business initiative that has a heart: Lupin eyes Lyfe beyond the pill

Its digital health initiative for cardiac patients is part of its strategy to diversify into healthcare services

Pharma major Lupin is diversifying itself to go “beyond the pill” to touch patient lives. Having forayed into the diagnostics business in December 2021, the Mumbai-headquartered Rs 12,000-crore drug major, best known for its suite of drugs to treat tuberculosis, has now launched a digital health initiative for cardiac patients, and has plans to get into neurological rehabilitation centres in the near future.

Do these initiatives make business sense?

Analysts said these businesses were unlikely to make any meaningful contribution to Lupin’s topline. But these are strategic marketing ideas. “Today, we are debating on ethical and unethical pharmaceutical marketing practices,